My bookmarksSign up free

Commission Delegated Regulation (EU) 2017/1569 Article 5

Commission Delegated Regulation (EU) 2017/1569 Article 5

Pharmaceutical quality system

Article 5

1.   The manufacturer shall establish, implement and maintain effective organised arrangements to ensure that the investigational medicinal products are of the quality required for their intended use. Those arrangements shall include the establishment of a good manufacturing practice and a quality control. 2.   Senior management and personnel from different departments shall participate in the establishment of the pharmaceutical quality system.

Read the full instrument → · Read this in context: CHAPTER II — GOOD MANUFACTURING PRACTICE →

Other provisions in CHAPTER II — GOOD MANUFACTURING PRACTICE

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 5 of Commission Delegated Regulation (EU) 2017/1569 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next